Special Issues

Emerging MOAs in Multiple Myeloma: Updates From the 17th IMW

Volume: 1
Issue: 1

Developments in NRG1 Fusion+ Cancers

Volume: 1
Issue: 1

The Changing Chronic Lymphocytic Leukemia Treatment Paradigm

Volume: 1
Issue: 1

The Role of Folate Receptor Alpha in the Treatment of Ovarian Cancer

Volume: 1
Issue: 1

Focus on Pathways: Inhibition of the BCL-2 Pathway in Hematologic Malignancies

Volume: 1
Issue: 1

ASCO 2019: Therapeutic Updates in Melanoma

Volume: 1
Issue: 1

Focus on Pathways: Historical Perspective and Current Considerations in Hairy Cell Leukemia

FGFR Inhibition in Cholangiocarcinoma: Update from the 2018 ESMO Congress

Volume: 1
Issue: 1

The Rationale for Bruton Tyrosine Kinase Inhibition in B-Cell Lymphomas

Focus on Pathways: Emerging Mutations in Lung Cancer and Other Solid Tumors

Focus on Pathways: NTRK Gene Fusions

Focus on Pathways: Therapeutic Inhibition of XPO1- Mediated Nucleocytoplasmic Transport With SINE Technology

Focus on Pathways: Next-Generation Sequencing to Support Immuno-Oncology Therapy: The Emerging Role of Tumor Mutational Burden

Focus on Pathways: Novel Targeted Antibody-Drug Conjugates in Non-Hodgkin Lymphoma

Immuno-Oncology

Volume: 1
Issue: 1

Anti-PD-1/PD-L1 Immunotherapy in Lung Cancer: Updates From the ESMO 2016 Congress

June 2015

Volume: 1
Issue: 1